John K. Scott Jr. - Nov 30, 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director, 10%+ Owner
Signature
/s/ Erika L. Eves for John K. Scott, Jr., by power of attorney
Stock symbol
NAVB
Transactions as of
Nov 30, 2022
Transactions value $
$0
Form type
4
Date filed
11/30/2022, 03:11 PM
Previous filing
Nov 1, 2022
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +1.25K +0.02% $0.00 8.11M Nov 30, 2022 Direct F1, F2
holding NAVB Common Stock 10.1K Nov 30, 2022 By spouse and children F3
holding NAVB Series G Redeemable Preferred Stock 3.26K Nov 30, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F2 Issuance deferred at the request of the Reporting Person.
F3 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.